Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2502 of 5804
-
New shot may help cancer patients keep weight during chemo
Symptom relief Recruiting nowThis is a randomized, double-blind, placebo-controlled basket trial evaluating mifomelatide (TCMCB07) administered daily by subcutaneous (SC) injection in up to 120 patients. Patients will be enrolled into two cohorts 1) patients with newly diagnosed, advanced, unresectable color…
Phase: PHASE2 • Sponsor: Endevica Bio • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Experimental drug ALN-CIDEB targets fatty liver in early trial
Disease control Recruiting nowThis study is researching an experimental drug called ALN-CIDEB, also referred to as "study drug". The study is focused on participants with metabolic dysfunction-associated steatotic liver disease (MASLD) (Part A) and metabolic dysfunction-associated steatohepatitis (MASH) (Part…
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Experimental flu vaccine enters human testing
⭐️ VACCINE ⭐️ Recruiting nowBackground: Vaccines help the body learn to fight infections. Some vaccines are combined with adjuvants, which are added substances that make vaccines work better. FluMos-v2 is an experimental flu vaccine; ALFQ is an experimental adjuvant. Objective: To test FluMos-v2, with an…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 23, 2026 00:00 UTC
-
New app aims to turn wearable data into diabetes Self-Care success
Symptom relief ENROLLING_BY_INVITATIONDay-to-day self-management by adults with type 2 diabetes, including glucose monitoring, taking medications, and healthy habits, is essential to avoid diabetes complications, yet, despite the rapidly expanding availability of wearable glucose and activity monitors, successful sel…
Phase: NA • Sponsor: Ann-Marie Rosland • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Can an 8-Week school program boost teen mental health? new study aims to find out
Knowledge-focused OngoingThe INSPIRE (Integrated Network for Student Psychosocial Intervention, Resilience, and Education) intervention is an 8-week, school-based mental health program designed to enhance adolescents' mental health literacy and resilience while addressing symptoms of depression and anxie…
Phase: NA • Sponsor: National University of Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Could this pill tame both depression and migraine? new study investigates
Symptom relief Recruiting nowDepression and migraine are among the most prevalent conditions in the general population, and many research shows they are closely related. Migraine is one of the most common debilitating diseases, affecting over one billion people worldwide. Migraine is frequently comorbid with…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Default option nudge may boost cancer screening in High-Risk groups
Knowledge-focused CompletedThe goal of this clinical trial is to learn if a behavioral "nudge" strategy, specifically a default option, can improve screening participation in populations at high risk for lung and stomach cancer. The main questions it aims to answer are: 1. Does presenting a screening appo…
Phase: NA • Sponsor: Harbin Medical University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
3D-Printed braces could fix underbites without surgery
Disease control Recruiting nowObjective: to evaluate the dentoskeletal effects of CAD/CAM 3D-Printed fixed twin block versus MARA appliances in the management of skeletal class II due to Mandibular Deficiency in Preadolescence Class II malocclusion is considered one of the most commonly observed problems amon…
Phase: NA • Sponsor: Mansoura University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for rare bone cancer: experimental drug ERAS-601 tested alone
Disease control OngoingThe researchers are doing this study is to find out whether ERAS-601 is a safe and effective treatment that causes few or mild side effects in people with advanced and progressing chordoma.
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Blood enzyme may reveal hidden clues in schizoaffective disorder
Knowledge-focused CompletedSchizoaffective disorder (SAD) is a severe psychiatric condition characterized by the coexistence of psychotic symptoms and mood episodes. Growing evidence suggests that immune dysregulation and inflammatory processes contribute to the pathophysiology of schizophrenia-spectrum di…
Sponsor: Elazığ Mental Health and Diseases Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New study aims to crack the code of head and neck cancer in korean patients
Knowledge-focused Recruiting nowStudy Background and Rationale Head and neck cancer (HNC) is the sixth leading cause of cancer-related death, with over 650,000 new cases diagnosed worldwide each year. About 60% of patients are diagnosed at an advanced stage, and many experience recurrence or spread despite surg…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Spud study: baked potatoes may help tame Pre-Diabetes
Disease control Recruiting nowThe goal of this clinical trial is to is to determine the effects of baked potato with the skin (BP) + nutrition education focused on adherence for a Mediterranean Dietary Pattern (MEDNE) on glycemic control, cardiometabolic health, and dietary quality in individuals with pre-dia…
Phase: NA • Sponsor: University of Nevada, Las Vegas • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Ultrasound vs. antibiotics: a new way to treat kids with pneumonia?
Knowledge-focused Recruiting nowPneumonia is a major cause of illness and death in children, with an annual incidence of about 3.3 per 1,000 in those under five years old, many requiring hospitalization. The diagnosis is challenging due to the absence of a universally accepted gold standard, leading to variabil…
Phase: NA • Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New inhaler hope for COPD patients in early trial
Disease control Recruiting nowTo evaluate the safety and efficacy of the HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension compared with the placebo in the treatment of Chinese patients with COPD.
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a simple diet change help kids with Ultra-Rare metabolic disorder?
Disease control Recruiting nowAICA-Ribosiduria due to ATIC deficiency is a rare genetic metabolic disease that affects less than 10 patients (PMID: 32557644). It results in severe polyhandicap linked to neurodevelopmental disorders, visual impairment, growth retardation, severe spinal deformities and scoliosi…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
AI hearing aids aim to cut through the chatter
Symptom relief Recruiting nowThe purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and speech perception for hearing impaired patients.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New cancer drug BR111 enters first human tests
Disease control Recruiting nowThis is a Phase I, multicenter, open-label, single-arm and first-in-human clinical study of BR111-101 for injection. The study objectives are to evaluate the safety, tolerability, pharmacokinetic profile, anti-tumor activity and immunogenicity of BR111-101 for injection in patien…
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug HRS-6768 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThe study is being conducted to evaluate the pharmacokinetics, radiation dosimetry, safety and preliminary efficacy of HRS-6768. To explore the reasonable dosage of HRS-6768 in the treatment of patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Tech-Boosted acupunch exercise shows promise for dementia patients
Symptom relief CompletedThis project was aimed to examine the effects of a six-month VA exercise program incorporated the SPOZ technology in improving the disease dysfunction and functional fitness deterioration of older adults with dementia in adult daycare centers.
Phase: NA • Sponsor: Kaohsiung Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Green light & brain zaps: new hope for migraine sufferers?
Symptom relief Recruiting nowAccording to the Global Burden of Disease (GBD) study, headache disorders are among the most prevalent and disabling conditions worldwide, with estimated 1-year prevalence of migraine (22.5%) in Pakistan, considerably higher than the global 1-year prevalence of 15%. The treatmen…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC